baber/WOPTO huggingface dataset:
Patent JP-4159109-B2 (JP)
IPC: A61P31/00
Filed: 1996-12-24
Granted: 2008-10-01
Abstract: 1. Use of a compound of the formula <CHEM> in which:  one of R<1> and R<2> is R<3>-X and the other is hydrogen, nitro, cyano, trifluoromethyl, carbo(lower)alkoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, lower alkyl, alkylamino, lower alkoxy, halo, HF2CO, F3CO or R<3>-X-; R<3> is monocycloalkyl, bicycloalkyl or benzocycloalkyl of up to 18 carbon atoms, tetrahydropyran or tetrahydrofuran; X is a carbon-carbon bond, -CH2-, -O- or -N=; R<5> is (i) o-phenylene, unsubstituted or substituted with 1 or more substituents each selected independently from nitro, cyano, halo, trifluoromethyl, carbo(lower)alkoxy, acetyl, or carbamoyl, unsubstituted or substituted with lower alkyl, acetoxy, carboxy, hydroxy, amino, lower alkylamino, lower acylamino, aminoalkyl, or lower alkoxy; (ii) the vicinally divalent residue of pyridine, pyrrolidine, imidizole, naphthalene, or thiophene, wherein the divalent bonds are on vicinal ring carbon atoms; (iii) a vicinally divalent cycloalkyl or cycloalkenyl of 4-10 carbon atoms, unsubstituted or substituted with one or more substituents each selected independently from the group consisting of nitro, cyano, halo, trifluoromethyl, carbo(lower)alkoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, lower alkylamino, lower alkyl, lower alkoxy, or phenyl; (iv) vinylene di-substituted with lower alkyl; or (v) ethylene, unsubstituted or monosubstituted or disubstituted with lower alkyl; R<6> is -CO-, -CH2- or -CH2CO-; Y is -COZ, -CN, -OR<8>, lower alkyl or aryl, Z is -NH2, -OH, -NHR, -R<9>, or -OR<9>; R<8> is hydrogen or lower alkyl; R<9> is lower alkyl or benzyl, and n has a value of 0, 1, 2, or 3,  wherein the term "lower" denotes from 1 to 6 carbon atoms, for the manufacture of a medicament for treating cancer.
Patent JP-3731673-B2 (JP)
IPC: A61M60/515
Filed: 1996-02-06
Granted: 2006-01-05
Abstract: A heart pacemaker (6), in particular an external heart pacemaker, which comprises means for stimulating the heart and means for perceiving spontaneous cardiac activity, contains an additional device in the form of an additional module (8) for forming a pulse (PR) which is coupled in a fixed manner in terms of time to the perception of spontaneous ventricular cardiac activity and coupled in a manner which is fixed in terms of time but offset by a given interval (t) to the emission of a ventricular stimulation pulse. The pulse emitted by the additional module (8) is used to control the logics of a balloon pump (10, 12, 9, 3). The additionally formed pulse has the approximate shape and amplitude of a patient's natural ECG R wave occurring at the body surface, such that it can be "understood" by the ECG input of the pump control system (4), as is conventional for the normally derived surface ECG. The pacemaker has low source impedance. A separate pacemaker (6) can be assembled with or connected to an intra-aortal balloon counter-pulsation system (IABP) of this type.
Patent JP-4025364-B2 (JP)
IPC: A42B3/10
Filed: 1995-03-21
Granted: 2007-12-19
Abstract: PCT No. PCT/EP95/01056 Sec. 371 Date Dec. 5, 1996 Sec. 102(e) Date Dec. 5, 1996 PCT Filed Mar. 21, 1995 PCT Pub. No. WO95/25446 PCT Pub. Date Sep. 28, 1995Protective helmet (10), in particular for motorcyclists or the like, with an outer casing formed in particular as an outer shell (11) and a lining (12) which is accommodated in the outer casing and lines the latter at least in areas. At least in partial regions, the lining (12) comprises a cushion which can be evacuated of air, is divided into individual segments (13, 14, 15, 16) and is filled with resilient packing (38).
Patent JP-3629034-B2 (JP)
IPC: D21H15/02
Filed: 1995-03-20
Granted: 2005-03-16
Abstract: Individualized, chemically crosslinked high-bulk cellulosic fibers comprising cellulosic fibers chemically intra-fiber crosslinked with a polycarboxylic acid crosslinking agent selected from the group consisting of tartaric acid and malic acid and mixtures thereof optionally further comprising the addition of one or more crosslinking agents selected from poly(acrylic acid), poly(methacrylic acid), poly(maleic acid), poly (methylvinylether-co-maleate) copolymer, poly(methylvinylether-co-itaconate) copolymer, citric acid, succinic acid, glutaric acid, citraconic acid, maleic acid, itaconic acid, tartrate monosuccinic acid and mixtures thereof. A method of making individualized chemically intra-fiber crosslinked high-bulk fibers comprises applying a polycarboxylic acid crosslinking agent to a mat of cellulosic fibers and curing the crosslinking agent to form intra-fiber crosslinks. <IMAGE>
Patent JP-3819935-B2 (JP)
IPC: C12N9/74
Filed: 1996-02-23
Granted: 2006-09-13
Abstract: PCT No. PCT/GB96/00423 Sec. 371 Date Nov. 20, 1997 Sec. 102(e) Date Nov. 20, 1997 PCT Filed Feb. 23, 1996 PCT Pub. No. WO96/26269 PCT Pub. Date Aug. 29, 1996A process for preparing thrombin which comprises treating a mixture comprising prothrombin, factor Xa, factor Va, and phospholipids with calcium ions, at a pH of 6.0-7.0 is provided. In particular the pH of 6.0-7.0 may be generated by the addition of the calcium ions or by buffering the preparation to a pH of 6.0-7.0. Thrombin preparations so produced may be subjected to further purification and are particularly stable even when substantially free of exogenous stabilizing agents such as proteins, sugars, polyol and mixtures thereof, and may be subject to freeze-drying and a virus inactivation by heat treatment.
Patent JP-4012257-B2 (JP)
IPC: C12P41/00
Filed: 1997-09-01
Granted: 2007-11-21
Abstract: An enzyme having carbonyl reduction activity of reducing a carbonyl compound asymmetrically to produce an optically active alcohol, a DNA coding the enzyme, a plasmid having the DNA, a transformant which is a cell transformed with the plasmid, and a production method of an optically active alcohol using the enzyme and/or the transformed cell are provided.
Patent JP-4368949-B2 (JP)
IPC: C07J9/00
Filed: 1998-02-25
Granted: 2009-11-18
Abstract: The invention relates to a process for the preparation of stanol esters by hydrogenating a sterol blend in a hydrogenation solvent and at an elevated temperature in the presence of a hydrogenation catalyst, by removing the hydrogenation catalyst from the obtained hot reaction solution, by transesterifying the intermediate stanol blend with a fatty acid methyl ester at an elevated temperature and in the presence of a transesterification catalyst, and by finally purifying the stanol ester blend thus obtained. According to the invention, the intermediate stanol blend is neither crystallized nor removed from the reaction solution but the hydrogenation solvent is replaced therein at least in part by a transesterification reagent. Alternatively, the hydrogenation solvent may also be used as the transesterification solvent, and preferably also as the transesterification reagent.
Patent ES-2312295-B2 (ES)
Title: Dispositivo desfasador reconfigurable de radiofrecuencia para banda ku.
Inventor: SIERRA CASTANER MANUEL
IPC: H01P1/185
Filed: 2008-07-24
Granted: 2010-02-24
Abstract: Dispositivo desfasador reconfigurable de
radiofrecuencia para banda Ku, de dos puertas y con desfase
controlado por tensión, que comprende un acoplador híbrido (10) de
cuatro puertas, de 3 dB y 90º, con una puerta de entrada RF A y una
puerta de salida RF D, en el cual se conectan cada una de las
puertas intermedias B y C, con un circuito sintonizador (11)  de
sintonía variable de tipo circuito impreso, con tramos de línea de
alta impedancia, en sustitución de elementos  concentrados,
obteniendo un desfase entre 0º y 300º controlable
electrónicamente.
Patent ES-2367512-B2 (ES)
Title: Procedimiento para la fabricación de un envase pet coloreado.
Inventor: LEZA ROA FORTUN
IPC: C08K3/22
Filed: 2010-04-12
Granted: 2012-08-02
Abstract: Procedimiento para la fabricación de un envase PET coloreado caracterizado porque incorpora agentes absorbentes, tales como Fe{sub,3}O{sub,4} o negro de humo, a composiciones de PET coloreado, incorporando opcionalmente TiO{sub,2}, obteniendo la máxima protección a la luz en un amplio espectro de longitudes de onda mientras se mantiene transparente o translúcido el envase resultante.#Esta invención presenta la ventaja de combinar las propiedades de protección frente a luz de corta longitud de onda de un PET coloreado con las propiedades de protección frente a luz de larga longitud de onda del PET con opacificante, obteniendo un envase que permite ver el contenido, y lo protege de la luz.
Patent ES-2628278-B2 (ES)
Title: Formulación bioestimulante del crecimiento y desarrollo vegetal e inductora de resistencia para el control de enfermedades causadas por virus fitopatógenos y método de preparación
Inventor: YANEZ REYES JESÚS NOEL
IPC: A01P21/00
Filed: 2016-10-25
Granted: 2017-11-06
Abstract: Formulación bioestimulante del crecimiento y desarrollo vegetal e inductora de resistencia para el control de enfermedades causadas por virus fitopatógenos y método de preparación. La formulación bioestimulante del crecimiento y desarrollo vegetal e inductora de resistencia para el control de enfermedades causadas por virus fitopatógenos está compuesta por extractos y aceites vegetales provenientes de variedades de plantas del semidesierto Chihuahuense y aceites absolutos y extractos de plantas aromáticas, entre otros componentes. Un método para preparar la formulación bioestimulante que comprende preparación de la base de la formulación, adición de una premezcla que contiene extractos etanólicos de plantas, hormonas y reguladores de crecimiento vegetal y adición de extracto metanólico de Eucalyptus globulus, adición de una premezcla que contiene aceites absolutos y adición de extracto acetónico de Larrea tridentata y adición de una premezcla que contiene extractos hexánicos y de un agente acondicionador.
Patent AU-2001232649-B2 (AU)
Title: Spox-enhanced process for production of synthesis gas
Inventor: KELLER ALFRED E
IPC: C01B3/38
Filed: 2000-12-20
Granted: 2006-05-04
Abstract: A method, system and catalysts for improving the yield of syngas from the catalytic partial oxidation of methane or other light hydrocarbons is disclosed. The increase in yield and selectivity for CO and H2 products results at least in part from the substitution of H2S partial oxidation to elemental sulfur and water for the combustion of light hydrocarbon to CO2 and water.
Patent AU-2001248840-B2 (AU)
Title: Novel collectins
Inventor: WAKAMIYA NOBUTAKA
IPC: C07K14/785
Filed: 2001-04-23
Granted: 2005-06-09
Abstract: Provided are isolated collectin (CL-L2s) genes including a base sequence set out in SEQ ID NO: 1, 3, 5, 7, 9, 12, 36, 38 or 40 relating to a novel collectin which are expected to exhibit an antibacterial activity, an antiviral activity and the like particularly in a human body; and isolated collectin proteins including an amino acid sequence set out in SEQ ID NO: 2, 4, 6, 8, 10, 13, 37, 39 or 41 and derivatives and fragments thereof.
Patent AU-2001271928-B2 (AU)
Title: Cosmetic compositions
Inventor: VATTER MICHAEL LEE
IPC: A61Q19/00
Filed: 2001-07-09
Granted: 2005-03-24
Abstract: The invention relates to cosmetic compositions comprising a combination of non-emulsifying and emulsifying crosslinked siloxane elastomers.
Patent AU-2001273887-B2 (AU)
Title: Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
Inventor: SCHROEDER RIKKE L
IPC: A61P29/00
Filed: 2001-06-14
Granted: 2005-12-15
Abstract: The present invention relates to the use of substituted 3-phenyl oxindole derivatives as modulators of the potassium KCNQ channels, to pharmaceutical compositions comprising these compounds, and to methods of treatment herewith.
Patent AU-2002230270-B2 (AU)
Title: Rehydration composition
Inventor: VERLAAN GEORGE
IPC: A61P1/12
Filed: 2002-01-28
Granted: 2006-05-04
Abstract: The invention relates to a fluid that can be used for preventing or treating hypohydration and the secondary consequences thereof. The fluid comprises one or more carbohydrates and minerals and is further is characterized by a low osmolarity. The invention further relates to the use of such a fluid for medical, dietetic and other applications.
Patent AU-2002253795-B2 (AU)
Title: Synthesis of 4-Amino-Thalidomide enantiomers
Inventor: HUNSUCKER KIMBERLY A
IPC: A61P13/08
Filed: 2001-11-30
Granted: 2007-02-01
Abstract: The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.
Patent AU-2002304632-B2 (AU)
Title: Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
Inventor: PIERRO FRANCESCO DI
IPC: A61K8/63
Filed: 2002-05-16
Granted: 2006-07-20
Abstract: The present invention relates to pharmaceutical and/or cosmetic compositions containing a combination of the following active principles: a) complex of escin/beta-sitosterol with phospholipids, b) complex of Gingko biloba dimeric flavonoids with phospholipids, c) complex of Centella asiatica triterpenes with phospholipids, and optionally one or both of: d) ethyl ximeninate e) Coleus forskolii standardized extract.
Patent AU-2002359168-B2 (AU)
Title: Method and system for identification
Inventor: PETTERSSON ROLAND
IPC: B60R25/24
Filed: 2002-12-18
Granted: 2008-07-03
Abstract: Method for identification of a user (31, 32, 33) of rock drilling equipments (30), which rock drilling equipment includes functionality, whereof different parts are available for different user categories. Each user (31, 32, 33) is assigned at least one user category, and at identification of the user (31, 32, 33) the user identity or user category is transmitted to the rock drilling equipment (30) from a portable unit (34, 35, 36) via a wireless interface.
Patent AU-2003218632-B2 (AU)
Title: Wind turbine blade with carbon fibre tip
Inventor: GRABAU PETER
IPC: F03D1/06
Filed: 2003-03-19
Granted: 2009-01-08
Abstract: The invention relates to a wind turbine blade ( 14 ) of fibre-reinforced polymer. The blade ( 14 ) is divided into an inner end portion ( 15 ) including the blade root and made substantially from fibre glass-reinforced polymer, and an outer end portion ( 17 ) including the blade tip and made substantially from carbon fibre-reinforced polymer.
Patent AU-2003233260-B2 (AU)
Title: An installation tool
Inventor: PISONI SIMON NICHOLAS
IPC: H02G3/38
Filed: 2003-06-13
Granted: 2008-04-17
Abstract: A tool is disclosed for installing an object into a cavity region. The tool includes an identifying means for providing a visual indication of an entry point for lowering the object into the cavity region. The entry point is relative to an opening in the cavity region. The tool also includes a capturing means for capturing the object after the object has been lowered into the cavity region from the entry point so as to allow the object to be retracted through the opening. The tool has a body which carries the identifying means and the capturing means. Part of the body is arranged so as to allow at least the identifying means and the capturing means to be inserted into the cavity region through the opening.
Patent AU-2003268429-B2 (AU)
Title: Apparatus for producing a metallic slurry material for use in semi-solid forming of shaped parts
Inventor: WANG SHAUPOH
IPC: F27D9/00
Filed: 2003-09-02
Granted: 2008-01-24
Abstract: An apparatus for producing a metallic slurry material for use in semi-solid forming of a shaped part. The apparatus is generally comprised of a forming vessel and a thermal jacket. The forming vessel defines an inner volume for containing the metallic slurry material and has an outer surface. The thermal jacket has an inner surface disposed in thermal communication with the outer surface of the forming vessel to effectuate heat transfer therebetween. At least one of the forming vessel and the thermal jacket defines a number of grooves to limit the rate of heat transfer adjacent the grooves. In one embodiment, the forming vessel defines a plurality of axially-offset grooves extending about the entire periphery of the outer surface of the forming vessel. In another embodiment, a stator is disposed about the thermal jacket to impart an electromagnetic stirring force to the metallic slurry material contained within the forming vessel.
Patent AU-2004200611-B2 (AU)
Title: Locking stent
Inventor: FLEMING JAMES A III
IPC: A61F2/84
Filed: 2004-02-16
Granted: 2009-08-27
Abstract: A locking stent has a lattice of interconnecting elements defining a substantially cylindrical configuration having a first open end and a second open end. The lattice has a closed configuration and an open configuration. The lattice has a plurality of adjacent hoops in which each hoop is separated from another hoop in the closed configuration. Each hoop mateably connects with or interlocks with an adjacent hoop in the open configuration.
Patent AU-2004211945-B2 (AU)
Title: Articulating implant system
Inventor: PATTERSON STUART D M D
IPC: A61F2/00
Filed: 2004-02-05
Granted: 2008-04-24
Abstract: An articulating implant system is provided for fixation to a bone. The articulating implant system includes a fixation component for fixation to the bone and an articulating member for articulating against bone or cartilage. Specifically, a modular ulnar implant is provided in accordance with the articulating implant system of the present invention wherein the fixation component is a stem for insertion into the intramedullary canal of the distal ulna and the articulating member is a head for articulating with the radial sigmoid notch.
Patent AU-2004225971-B2 (AU)
Title: Polymerizable modified particles and methods of using the same
Inventor: SCHNEIDER JOHN R
IPC: C09D7/62
Filed: 2004-03-25
Granted: 2007-04-19
Abstract: Coating compositions having improved mar and scratch resistance are disclosed. The coatings generally comprise one or more polymers comprising a monomer formed between a particle having a functional group and a modifying group having ethylenic unsaturation. The improved resistance can be achieved without affecting the appearance or mechanical performance of the coatings. Methods for using the coatings, and the substrates coated therewith, are also disclosed, as are the monomers and polymers that comprise the coatings.
Patent AU-2004247470-B2 (AU)
Title: Thienopyrimidine derivatives as potassium channel inhibitors
Inventor: PALMER NICHOLAS JOHN
IPC: C07D495/04
Filed: 2004-06-10
Granted: 2009-04-23
Abstract: The present invention provides thienopyrimidine compounds which are potasium channels inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia are also provided.
Patent AU-2005299730-B2 (AU)
Title: Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-Jun N terminal kinases (JNK) and p-38 kinases
Inventor: DONG QING
IPC: C07D487/04
Filed: 2005-10-25
Granted: 2009-11-12
Abstract: A compound of formula (I): wherein the substituents are as defined in the specification as inhibitor of C-Jun N terminal Kinases (JNK) and P-38 Kinases.
Patent AU-2005309693-B2 (AU)
Title: Cream cheese product and its method of preparation
Inventor: EIBEL HERMANN
IPC: A23C21/06
Filed: 2005-11-21
Granted: 2011-02-10
Abstract: The invention relates to a cream cheese product obtainable by a process comprising the steps of:  (a)  acidifying a whey protein concentrate with a food grade acidulant or with starter bacteria to reduce the pH to more than 4.5 to about 5.2,  (b)  heating the acidified whey protein concentrate of step (a) slowly to a temperature of about 75° to about 90°C and maintaining it for at least about 30 min to produce a functional whey protein concentrate,  (c)  optionally blending the whey protein concentrate of step (b) with milk fat in a weight ratio of about 60:40 to about 100:0 wherein step (c) may be carried out before step (b),  (d)  homogenizing the blend obtained in step (b) or (c) in a 2-stage high-pressure homogenizer at pressures of about 300-400/50-80 bar and a temperature of about 5° to about 75°C to produce an emulsified functional whey protein concentrate,  (e)  blending the product of step (d) with curd the fat content of which is adjusted in accordance with the milk fat portion added in step (c) and with the desired product, and adding salt and optional stabilizers, and  (f)  homogenizing the product of step (e) in a 2-stage high-pressure homogenizer at pressures of about 300-400/50-80 bar and at a temperature of about 68° to about 90°C.
Patent AU-2006202808-B2 (AU)
Title: Trolley
Inventor: JAMES KEMP PETER
IPC: B62B3/04
Filed: 2006-07-03
Granted: 2011-12-15
Abstract: -10 A trolley comprises a frame which is constructed having storage means and moving means. The storage means is adapted to allow equipment to be stored therein and the moving means 5 allows the trolley to be easily moved with or without any equipment stored thereon. Al
Patent AU-2006203640-B2 (AU)
Title: Therapeutic use of a recombinant erythropoietin for prevention or treatment of chronic heart failure and associated fatigue or pain
Inventor: THOMPSON LAWRENCE H
IPC: A61K33/24
Filed: 2006-08-17
Granted: 2009-01-08
Abstract: The invention discloses several novel therapeutic properties and methods of treatment using the recombinant erythropoietin prepared by expression from the Apa I restriction fragment of human genomic erythropoietin DNA transformed into baby hamster kidney cells (BHK) according to U.S. Patent No. 5,688,697 to Powell. This recombinant erythropoietin designated herein as Epoetin Omega is shown to possess several unexpected and superior qualities over other recombinant erythropoieteins such as those designated Epoetin Alfa and Beta which are prepared from genomic or cDNA expressed in Chinese Hamster Ovary (CHO) according to U.S. Patent Nos. 4,703,008 and 5,955,422 to Lin. The superior properties of Epoetin Omega include, but are not limited to, a much higher potency, a much more rapid response (i.e. no latency), longer effective serum levels, much lower antigenicity in human subjects, therapeutic activity in subjects non-responsive to the other epoetins, fewer adverse side effects such as incidents of thrombosis, reduced nausea, reduced pain at the site of injection, reduction in body pain, and most significantly, the absence of, or reduced risk of, increased blood pressure or hypertension. These novel properties provide for novel therapeutic methods including, treatment of anemia and treatment of conditions other than anemia such as fatigue or vascular pain, treatment in patients adversely effected by hypertension such as patients with heart conditions or at increased risk of thrombosis, treatment in oncology settings with and without chemotherapy or radiation therapy, and treatment with novel dosing regiments that include much lower doses and lower administration frequencies of as few as once per week or less.